 |
The Promise of Personalized MedicineAuthor: Perry Dimas
There is no personalized medicine without a diagnostic test to help in the process. The Promise of Personalized Medicine is a podcast that explores the process of creating more personalized medicine and the Medical Directors who ensure that the right care is being delivered to us all. Season 1 will focus on understanding best practices by using the Blueprint of Success format as a template for labs to use when trying to get their novel diagnostic test approved by health plans. This is The Promise of Personalized Medicine. Language: en-us Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Access, Guidelines, and the Gap in Personalized Medicine w/ Dr. Federico Monzon
Episode 3
Monday, 9 February, 2026
What does personalized medicine really mean—and why does it remain so difficult to implement at scale?In this episode, Perry is joined by longtime colleague and molecular pathology expert Dr. Frederico Monzon for an in-depth conversation on the realities behind personalized medicine. Drawing from his experience across academia, clinical practice, and industry, Frederico reframes personalized medicine as not only identifying the right treatment—but also avoiding therapies that offer no benefit and may cause harm.In this episode, you’ll hear about:How personalized medicine has long existed in pathology, even before the term became a buzzwordWhy avoiding ineffective treatments is just as critical as finding the right oneThe ongoing challenge of access to diagnostic testing and actionable informationWhy many patients still aren’t tested—even when guidelines and coverage existThe role of clinical guidelines as guardrails, not rigid rulesTensions and opportunities between laboratories, insurers, and lab benefit managersHow unmet clinical need drives meaningful innovation in diagnosticsWhy collaboration across industry, academia, and payers is essentialWhat excites Frederico most about the future: multimodal medicine combining genomics, pathology, imaging, clinical data, and AIThe conversation closes with a forward-looking discussion on how breaking down data silos—and using AI responsibly—could help healthcare teams deliver more precise, cost-effective care tailored to each individual patient.—-------Stay connected with our host, Perry Dimas, here on LinkedIn! 📧 Interested in joining our medical director advisory group? Email us at info@accessdx.com 🔗 Connect on LinkedIn: linkedin.com/company/accessdx
